Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.


Stem cells harvested from peripheral blood are the most commonly used graft source in hematopoietic stem cell transplantation. While G-CSF is the most frequently used agent for stem cell mobilization, the use of G-CSF alone results in suboptimal stem cell yields in a significant proportion of patients undergoing autologous transplantation. Plerixafor… (More)
DOI: 10.1517/14712598.8.11.1797


  • Blog articles referencing this paper

  • Presentations referencing similar topics